Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Resolution of chronic synovitis with Emicizumab?
Emicizumab continues to reshape our understanding of joint outcomes in severe Hemophilia A — transforming not only bleeding prevention, but also long‑term joint health.
At EAHAD2026, this poster by Matteo Di Minno, using HEAD‑US and HJHS in 52 adults on long‑term Emicizumab prophylaxis showed:
- Significant improvement in hypertrophic synovium scores over ≥2 years
- >50% of joints with hypertrophic synovium at baseline showed reduction or resolution
- Very few de‑novo HS findings in previously unaffected joints, suggesting structural joint protection in routine practice
Interestingly, joints with pre‑existing degenerative changes improved the least – a strong reminder that timing of effective prophylaxis still matters.
It will be particularly interesting to see how these real‑world imaging data will align with the ongoing Phase IV Beyond ABR study (NCT05181618), which is exploring broader health and joint outcomes under Emicizumab.”
Find more posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Oct 13, 2026, 21:05Francisco Chacón-Lozsán: Heparin-Induced Thrombocytopenia – When an Anticoagulant Triggers Thrombosis
-
Oct 13, 2026, 21:04Aref Zribi: Isolated Tumor Thrombus and the Role of Prophylactic Anticoagulation
-
Oct 13, 2026, 21:01Alex Larson: Why Normal Bloodwork Does Not Always Tell the Whole Story
-
Oct 13, 2026, 20:58Juan Jauregui-Lozano: How Replication Stress Impairs Red Blood Cell Maturation
-
Oct 13, 2026, 20:55Caitlin Raymond: Understanding Platelet Refractoriness Before Ordering More Platelets
-
Oct 13, 2026, 20:54Sanja Seratlic: How Cow Feeding Systems Influence the Anti-Platelet Properties of Cheddar Cheese
-
Oct 13, 2026, 20:50Ruchika Goel: Cord Blood Red Blood Cells as a Physiologically Aligned Transfusion Strategy
-
Oct 13, 2026, 20:47Sophia Delicou: Strengthening Transfusion Safety Through Advanced Screening and Haemovigilance
-
Oct 13, 2026, 20:45Lydia Pecker: Alloimmunization and Transfusion Indications in Sickle Cell Disease Pregnancy